Author Topic: Ibudilast receives fast track designation--studied for SPMS and PPMS (MSAA Research News)  (Read 386 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Phase 2 trial of ibudilast in progressive MS (NEJM)
« on: August 29, 2018, 02:32:01 pm »

This study, which involved both secondary and primary progressive MS patients, was funded by a large number of major organizations.



Quote
Supported by grants from the National Institute of Neurological Disorders and Stroke (NINDS) (U01NS082329) and the National Multiple Sclerosis Society (RG 4778-A-6) and by MediciNova through a contract with the National Institutes of Health (NIH). The NeuroNEXT Network is supported by the NINDS (Central Coordinating Center, U01NS077179; Data Coordinating Center, U01NS077352; and individual grants to each trial site). Research reported in this article was also supported by grants from the National Center for Advancing Translational Sciences of the NIH to Case Western Reserve University (UL1 TR000439), Columbia University Medical Center (UL1 TR 000040), Montefiore Medical Center (UL1 TR002556), Oregon Health and Science University (UL1TR0002369), University of Cincinnati (UL1 TR001425-03), University of Colorado Denver (KL2 TR001080), Washington University in St. Louis (UL1 TR000448), and Weill Cornell Medical Center (UL1 TR000457).
The link below is to an abstract in the New England Journal of Medicine (August 30, 2018):
https://www.nejm.org/doi/full/10.1056/NEJMoa1803583?query=TOC
« Last Edit: August 30, 2018, 08:57:08 pm by agate »
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
1 Replies
211 Views
Last post November 14, 2018, 04:04:14 pm
by agate
0 Replies
60 Views
Last post February 02, 2019, 03:59:52 pm
by agate
0 Replies
60 Views
Last post March 21, 2019, 04:33:52 pm
by agate
0 Replies
63 Views
Last post April 04, 2019, 04:14:29 pm
by agate
0 Replies
14 Views
Last post April 18, 2023, 09:42:30 pm
by agate